Company: MDCXW
Filing Date: 2025-09-29
Form Type: S-1
Source: 0001062993-25-015839
Chunk: 271

Company: Medicus Pharma Ltd.
Filing Date: 2025-09-29
Form: S-1
Chunk 271
---
 liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, the accounting guidance establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value as follows:

: Observable inputs such as quoted prices in active markets;

: Inputs, other than the quoted prices in active markets that are observable either directly or indirectly; and

: Unobservable inputs in which there is little or no market data, or which require the reporting entity to develop its own assumptions.

The following table presents information about the Company's financial assets and liabilities measured at fair value on a recurring basis and indicate the level of the fair value hierarchy utilized to determine such fair values:

|                                          |   | June 30, 2025 |     |   |         |     |   |           |     |   |           |
|:-----------------------------------------|:--|--------------:|:----|:--|:--------|:----|:--|----------:|:----|:--|----------:|
|                                          |   |       Level 1 |     |   | Level 2 |     |   |   Level 3 |     |   |     Total |
| Current assets:                          |   |               |     |   |         |     |   |           |     |   |           |
| Money market funds                       | $ |     8,273,495 |     | $ | -       |     | $ |         - |     | $ | 8,273,495 |
| Total assets measured at fair value      | $ |     8,273,495 |     | $ | -       |     | $ |         - |     | $ | 8,273,495 |
| Liabilities:                             |   |               |     |   |         |     |   |           |     |   |           |
| Debentures                               | $ |             - |     | $ | -       |     | $ | 4,700,000 |     | $ | 4,700,000 |
| Total liabilities measured at fair value | $ |             - |     | $ | -       |     | $ | 4,700,000 |     | $ | 4,700,000 |

|                                     |   | December 31, 2024 |     |   |         |     |